Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Winston-Salem, North Carolina 27157


RATIONALE: Cholecalciferol (vitamin D) may improve quality of life by increasing blood counts, decreasing fatigue, and improving other symptoms of myelodysplastic syndrome. PURPOSE: This phase II trial is studying how well cholecalciferol works in treating patients with myelodysplastic syndrome.

Study summary:

OBJECTIVES: - Determine the efficacy of cholecalciferol, in terms of hematological improvement, in patients with low- or intermediate-risk myelodysplastic syndromes. - Determine the effect of this drug on disease symptoms, fatigue, and the overall health-related quality of life of these patients. OUTLINE: This is an open-label, pilot study. Patients receive oral cholecalciferol once daily. Treatment continues for 6 months in the absence of disease progression or unacceptable toxicity. PROJECTED ACCRUAL: A total of 36 patients will be accrued for this study.


DISEASE CHARACTERISTICS: - Histologically confirmed myelodysplastic syndromes (MDS) - Must have undergone bone marrow aspirate and biopsy with karyotype within the past 3 months - International Prognostic Scoring System score of 0 or 1 PATIENT CHARACTERISTICS: Age - Any age Performance status - Any Life expectancy - More than 1 year Hematopoietic - Not specified Hepatic - Not specified Renal - No history of hypercalcemia PRIOR CONCURRENT THERAPY: Biologic therapy - Prior stem cell transplantation allowed - No concurrent hematopoietic growth factors Chemotherapy - Not specified Endocrine therapy - Not specified Radiotherapy - Not specified Surgery - Not specified Other - More than 6 weeks since prior cholecalciferol supplements or analogs - More than 4 weeks since any prior therapy for MDS (except supportive care) - No other concurrent therapy for MDS



Primary Contact:

Study Chair
Istvan Molnar, MD
Wake Forest University Health Sciences

Backup Contact:


Location Contact:

Winston-Salem, North Carolina 27157
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: June 25, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.